BRPI0614566A2 - derivados de 2-oxo azepan subtituìdos por fluoro - Google Patents
derivados de 2-oxo azepan subtituìdos por fluoroInfo
- Publication number
- BRPI0614566A2 BRPI0614566A2 BRPI0614566-3A BRPI0614566A BRPI0614566A2 BR PI0614566 A2 BRPI0614566 A2 BR PI0614566A2 BR PI0614566 A BRPI0614566 A BR PI0614566A BR PI0614566 A2 BRPI0614566 A2 BR PI0614566A2
- Authority
- BR
- Brazil
- Prior art keywords
- substituted
- fluoro
- halogen
- lower alkyl
- heteroaryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D223/12—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
DERIVADOS DE 2-OXO AZEPAN SUBTITUìDOS POR FLUORO. Trata-se de compostos da fórmula geral (I), onde R^ 1^ é alquila inferior substituida por halogênio, ou é arila ou heteroarila, não-substituida ou substituida por halogênio; R^ 2^ é heterocicloalquila, arila ou heteroarila, que são não-substituidas ou substituidas por um ou mais substituintes, selecionados do grupo que consiste em halogênio, alquilóxi interior, alquila inferior substituida por halogênio, O-alquila inferior substituida por halogênio ou são substituidas por C(O)NR"2, (CR2 22)2 m2C(O)R', heteroarila ou S(O)2 22-alquila inferior; R^ 3^/R^ 3'^, R^ 4^/R^ 4^ e R^ 5^/R^ 5^ são independentemente um do outro hidrogênio ou fluoro, onde pelo menos um entre R^ 4^/R^ 4'^ ou sempre é fluoro; R' é arila ou hidróxi; R" é hidrogênio, cicloalquila ou é heterocicloalquila; R é hidrogênio ou alquila inferior; m é 0,1, 2 ou 3; e de sais de adição de ácido farmaceuticamente aceitáveis, enantiómeros opticamente puros, racematos ou misturas diastereoméricas destes. Foi verificado que os compostos da fórmula geral (1) são inibidores de y-secretase e os compostos relacionados podem ser úteis no tratamento de doença de Alzheimer ou cânceres comuns que incluem, porém sem caráter limitativo, carcinomas cervicais e carcinomas de mama e malignidades do sistema hematopoiético.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05107455 | 2005-08-12 | ||
PCT/EP2006/064935 WO2007020190A1 (en) | 2005-08-12 | 2006-08-02 | Fluoro substituted 2-oxo azepan derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0614566A2 true BRPI0614566A2 (pt) | 2009-08-04 |
Family
ID=37102441
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0614566-3A BRPI0614566A2 (pt) | 2005-08-12 | 2006-08-02 | derivados de 2-oxo azepan subtituìdos por fluoro |
Country Status (19)
Country | Link |
---|---|
US (1) | US7501406B2 (pt) |
EP (1) | EP1915345B1 (pt) |
JP (1) | JP4885958B2 (pt) |
KR (1) | KR101020397B1 (pt) |
CN (1) | CN101238106B (pt) |
AR (1) | AR055370A1 (pt) |
AT (1) | ATE492536T1 (pt) |
AU (1) | AU2006281493A1 (pt) |
BR (1) | BRPI0614566A2 (pt) |
CA (1) | CA2619223A1 (pt) |
DE (1) | DE602006019103D1 (pt) |
ES (1) | ES2355581T3 (pt) |
IL (1) | IL189026A0 (pt) |
MX (1) | MX2008001833A (pt) |
NO (1) | NO20080498L (pt) |
RU (1) | RU2419611C2 (pt) |
TW (1) | TWI325421B (pt) |
WO (1) | WO2007020190A1 (pt) |
ZA (1) | ZA200800930B (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2667802A1 (en) * | 2006-11-03 | 2008-05-29 | Northwestern University | Multiple sclerosis therapy |
FR2913886B1 (fr) | 2007-03-22 | 2012-03-02 | Guerbet Sa | Utilisation de nanoparticules metalliques dans le diagnostique de la maladie d'alzheimer |
GB201009603D0 (en) | 2010-06-08 | 2010-07-21 | Cambridge Entpr Ltd | Anti-inflammatory agent |
WO2012014127A1 (en) | 2010-07-30 | 2012-02-02 | Ranbaxy Laboratories Limited | 5-lipoxygenase inhibitors |
AR097279A1 (es) | 2013-08-09 | 2016-03-02 | Actelion Pharmaceuticals Ltd | Derivados de benzimidazolil-metil urea como agonistas del receptor de alx |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2001253108A1 (en) * | 2000-04-03 | 2001-10-15 | Bristol-Myers Squibb Pharma Company | Cyclic lactams as inhibitors of a-beta protein production |
ZA200507806B (en) * | 2003-03-24 | 2007-03-28 | Actimis Pharmaceuticals Inc | 2-phenoxy- and 2-enysulfomamide derivatives with CCR3 antagonistic acitivity for the treatment of asthma and other inflammatory or immunolgical disorders |
RU2364587C2 (ru) * | 2003-10-29 | 2009-08-20 | Элан Фармасьютикалз, Инк. | N-замещенные бензолсульфонамиды |
CA2573372A1 (en) * | 2004-07-13 | 2006-01-19 | F. Hoffmann-La Roche Ag | Sulfonamide derivatives |
-
2006
- 2006-08-02 AT AT06792637T patent/ATE492536T1/de active
- 2006-08-02 RU RU2008103452/04A patent/RU2419611C2/ru not_active IP Right Cessation
- 2006-08-02 DE DE602006019103T patent/DE602006019103D1/de active Active
- 2006-08-02 EP EP06792637A patent/EP1915345B1/en not_active Not-in-force
- 2006-08-02 BR BRPI0614566-3A patent/BRPI0614566A2/pt not_active IP Right Cessation
- 2006-08-02 JP JP2008525543A patent/JP4885958B2/ja not_active Expired - Fee Related
- 2006-08-02 ES ES06792637T patent/ES2355581T3/es active Active
- 2006-08-02 KR KR1020087003293A patent/KR101020397B1/ko not_active IP Right Cessation
- 2006-08-02 CN CN2006800285175A patent/CN101238106B/zh not_active Expired - Fee Related
- 2006-08-02 WO PCT/EP2006/064935 patent/WO2007020190A1/en active Application Filing
- 2006-08-02 CA CA002619223A patent/CA2619223A1/en not_active Abandoned
- 2006-08-02 AU AU2006281493A patent/AU2006281493A1/en not_active Abandoned
- 2006-08-02 MX MX2008001833A patent/MX2008001833A/es active IP Right Grant
- 2006-08-08 TW TW095129018A patent/TWI325421B/zh not_active IP Right Cessation
- 2006-08-08 US US11/500,662 patent/US7501406B2/en not_active Expired - Fee Related
- 2006-08-10 AR ARP060103496A patent/AR055370A1/es not_active Application Discontinuation
-
2008
- 2008-01-24 IL IL189026A patent/IL189026A0/en unknown
- 2008-01-28 NO NO20080498A patent/NO20080498L/no not_active Application Discontinuation
- 2008-01-29 ZA ZA200800930A patent/ZA200800930B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
ZA200800930B (en) | 2009-02-25 |
KR20080027936A (ko) | 2008-03-28 |
US20070037789A1 (en) | 2007-02-15 |
AU2006281493A1 (en) | 2007-02-22 |
JP2009504600A (ja) | 2009-02-05 |
TW200734308A (en) | 2007-09-16 |
EP1915345A1 (en) | 2008-04-30 |
EP1915345B1 (en) | 2010-12-22 |
IL189026A0 (en) | 2008-08-07 |
CN101238106B (zh) | 2011-02-16 |
KR101020397B1 (ko) | 2011-03-08 |
RU2419611C2 (ru) | 2011-05-27 |
TWI325421B (en) | 2010-06-01 |
AR055370A1 (es) | 2007-08-22 |
ATE492536T1 (de) | 2011-01-15 |
CA2619223A1 (en) | 2007-02-22 |
US7501406B2 (en) | 2009-03-10 |
WO2007020190A1 (en) | 2007-02-22 |
DE602006019103D1 (de) | 2011-02-03 |
RU2008103452A (ru) | 2009-09-20 |
JP4885958B2 (ja) | 2012-02-29 |
NO20080498L (no) | 2008-03-07 |
MX2008001833A (es) | 2008-04-09 |
CN101238106A (zh) | 2008-08-06 |
ES2355581T3 (es) | 2011-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA04003007A (es) | Compuestos azabiciclico sustituidos condensados con heteroarilo para el tratamiento de enfermedades. | |
MXPA04004464A (es) | Compuestos de heteroarilo sustituido con azabiciclo para el tratamiento de enfermedades. | |
BRPI0412347A (pt) | 2-aminofenil-4-fenilpiridinas como inibidores de quinase | |
PE20080670A1 (es) | COMPUESTOS DE 4-METILPIRIDOPIRIMIDINONA COMO INHIBIDORES DE LA FOSFOINOSITIDO 3-QUINASA ALFA (PI3-Ka) | |
MA27734A1 (fr) | DERIVES HEXAHYDROPYRAZINO [1,2-a]PYRIMIDINE-4,7-DIONE SUBSTITUES SUR L'AZOTE, METHODE POUR LEUR PRODUCTION ET LEUR UTILISATION EN TANT QUE MEDICAMENTS | |
MA27654A1 (fr) | DERIVES HEXAHYDROPYRAZINO [1,2-a]-4,7-DIONE SUBSTITUES, METHODE POUR LEUR PRODUCTION ET LEUR UTILISATION EN TANT QUE MEDICAMENTS | |
MX2007011695A (es) | Derivados de oxindol sustituido, medicamentos que contienen dichos derivados y uso de los mismos. | |
MA29539B1 (fr) | Procedes de production de derives phenoliques 4-biphenylylazetidin -2-one | |
BRPI0614566A2 (pt) | derivados de 2-oxo azepan subtituìdos por fluoro | |
TW200800962A (en) | Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions | |
CO6300861A2 (es) | Compuestos inhibidores de dipeptidil peptidasa iv metodos de preparacion de los mismos y composiciones farmaceuticas que los contienen como agentes activos | |
NO20054095L (no) | Pyridyloksymetyl og benzioksazolazabicyklisk derivater | |
TW200740795A (en) | Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions | |
IL186777A0 (en) | (3,4-dihydro-quinazolin-2-yl) - (2-aryloxy-ethyl) - amines having an activity on the 5 - ht receptor | |
ES2776680T3 (es) | Compuestos derivados de heterocicloalquilo como inhibidores selectivos de histona desacetilasa y composiciones farmacéuticas que los comprenden | |
BRPI0409739A (pt) | composto, composição farmacêutica, uso de composto, e, método para o tratamento de uma doença ou de um distúrbio | |
PE20090372A1 (es) | Derivados de indolinonas como inhibidores de quinasas especificas del ciclo celular | |
CN112442049A (zh) | 作为Wee1抑制剂的嘧啶衍生物 | |
DK1745010T3 (da) | Substituerede cyklohexyl-1,4-diaminderivater | |
PE20060103A1 (es) | Nuevas 5-acilindolinonas con contenido en cicloalquilo y su preparacion como medicamento | |
PE20050336A1 (es) | Compuestos triciclicos como inhibidores de la proteina farnesil transferasa | |
ES2776359T3 (es) | Quinazolin-thf-aminas halogenadas como inhibidores de PDE1 | |
WO2015009742A2 (en) | Compounds and methods for treating cancer, neurological disorders, ethanol withdrawal, anxiety, depression, and neuropathic pain | |
AR036735A1 (es) | Derivados de 5-metoxi-8-aril-[1,2,4]triazolo[1,5-a]piridina | |
JP2018536652A5 (pt) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUI DADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2214 DE 11/06/2013. |